Jas Kalsi
University College London
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jas Kalsi.
BJUI | 2005
Jas Kalsi; Suks Minhas; Nim Christopher; David J. Ralph
Associate Editor
BJUI | 2002
Rowland W. Rees; Jas Kalsi; Suks Minhas; J. Peters; P. Kell; David J. Ralph
Objective To evaluate the outcome of patients undergoing the immediate insertion of a penile prosthesis as a treatment for acute low‐flow priapism.
BJUI | 2006
Jas Kalsi; Nim Christopher; David J. Ralph; Suks Minhas
To assess the outcome of using modified human fascia lata (TutoplastTM, Mentor Corp, Santa Barbara, CA, USA) in the surgical management of Peyronie’s disease (PD), as the penile deformity associated with PD can be corrected by plaque incision and saphenous vein grafting (Lue procedure).
Expert Opinion on Investigational Drugs | 2002
Selim Cellek; Rowland W. Rees; Jas Kalsi
Approximately 50% of men aged over 40 suffer from male erectile dysfunction. Treatment options have widened since the launch of the phosphodiesterase type 5 (PDE5) inhibitor, sildenafil citrate (Viagra™). However, a certain portion of the patient population, such as diabetics, do not gain significant benefit from PDE5 inhibitors, possibly due to a lack of endogenous nitric oxide. Therefore, new treatment modalities based on the absence of endogenous nitric oxide have been developed. Among them are Rho-kinase inhibitors, soluble guanylate cyclase activators and nitric oxide-releasing PDE5 inhibitors. The available data concerning these compounds will be summarised and their therapeutic potential for male erectile dysfunction will be discussed.
BJUI | 2012
Jas Kalsi; Meen-Yau Thum; Asif Muneer; Hossam Abdullah; Suks Minhas
Study Type – Therapy (case series)
Reproductive Biomedicine Online | 2003
Jas Kalsi; Gulam Bahadur; Asif Muneer; Ozkan Ozturk; Nim Christopher; David J. Ralph; Suks Minhas
Erectile dysfunction (ED) affects the lives of approximately 150 million men worldwide. ED may be a cause of male sub-fertility in a significant proportion of patients. There is now an expanding armamentarium for the management of ED, including oral agents such as phosphodiesterase type 5 (PDE5) inhibitors. PDE5 inhibitors may also be useful in situations of temporary ED in couples undergoing IVF. Two novel PDE5 inhibitors have been commercially launched in the European Union in the first quarter of 2003. This article reviews the pharmacology and clinical efficacy of these new agents and their potential role in treating patients with male sub-fertility.
BJUI | 2004
Asif Muneer; Jas Kalsi; Nim Christopher; Suks Minhas; David J. Ralph
To analyse the outcome of plaque incision and grafting in patients who have a residual penile deformity after a Nesbit procedure for Peyronies disease, as a further Nesbit procedure may present difficulties in dissection at the previous operative site, and may result in further penile shortening.
BJUI | 2002
Jas Kalsi; Suks Minhas; Manit Arya; J.L. Peters; S.N. Venn; C.R.J. Woodhouse
A 35-year-old woman presented as an emergency complaining of right-sided abdominal pain, vomiting and abdominal distension. She also had a cough, increased difficulty in breathing and was febrile. Three years previously she had been diagnosed with tuberous sclerosis, bilateral renal angiomyolipomas (AMLs) and pulmonary lymphangio-leiomyomatosis (LAM). On admission her plasma creatinine level was 156 mmol/L and her haemoglobin level was 73 g/L. Initial management required intravenous resuscitation, broad-spectrum antibiotics and blood transfusion. At 72 h her respiratory and renal function deteriorated significantly and she was transferred to the intensive care unit for respiratory support and haemofiltration. Her respiratory function deteriorated further and the abdominal distension increased, requiring regular blood replacement and ultimately becoming transfusion dependent (although she was not haemodynamically compromised). CT of the abdomen revealed bleeding into the left kidney and retroperitoneal haemorrhage on the right side (Fig. 1). CT of the chest showed the abnormal features seen in LAM (Fig. 2). Renal angiography detected massively dilated renal arteries with the AMLs acting as arteriovenous shunts, but failed to identify active bleeding (Fig. 3); in view of her deteriorating clinical condition she underwent bilateral nephrectomy. At surgery two enormous kidneys were removed through a transverse anterior incision. The right kidney was 30 ¥ 21 ¥ 13 cm and weighed 3.828 kg, with the left kidney being even heavier (4.015 kg) and 30 ¥ 18 ¥ 1 cm. The patient made an impressive recovery, with normal respiratory function. Haemodialysis was commenced and the patient is currently awaiting a renal transplant.
The Journal of Urology | 2003
Jas Kalsi; Rowland W. Rees; Adrian J. Hobbs; Michael Royle; Phil D. Kell; David J. Ralph; Salvador Moncada; Selim Cellek
European Urology Supplements | 2010
Jas Kalsi; E. Zacharakis; A. Muneer; Suks Minhas